Figure 1.
Percentage of patients with different breast cancer molecular sub-types among the neurotrophic receptor tyrosine kinase amplified and non-amplified groups. Data are from TCGA breast cancer cohort. Black columns: Neurotrophic receptor tyrosine kinase amplified; Grey columns: Neurotrophic receptor tyrosine kinase non-amplified.
